港股異動 | 海螺創業(0586.HK)漲4.35% 2021年主業淨利潤增長4.86% 擬動用最多5億元購回股份
格隆匯3月29日丨海螺創業(0586.HK)漲4.35%,報22.8港元,總市值416億港元。該公司昨日發佈財報,截至2021年12月31日止年度,公司實現收入為人民幣83.50億元,同比增長26.43%;集團權益股東應占本年度主業淨利潤(扣除應占聯營公司利潤)人民幣12.90億元,較去年同期增長了4.86%;每股基本盈利為人民幣4.10元,董事會建議宣派末期現金股息每股0.70港元。公司根據股份購回計劃,自即日起至其後三個月止期間,擬動用最多約5億元在公開市場購回股份。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.